We hypothesize that some transcriptional pathways identified in the current analysis, including CREB, NRF-1 and SRF, may be additional novel molecular mediators of the transcriptomic phenotype associated with insulin resistance, and thus potential targets for future intervention strategies. The gene discussed is SRF; the disease is Insulin resistance.